Anti-SARS-CoV-2 Antibody Levels Measured by the AdviseDx SARS-CoV-2 Assay Are Concordant with Previously Available Serologic Assays but Are Not Fully Predictive of Sterilizing Immunity

With the availability of widespread SARS-CoV-2 vaccination, high-throughput quantitative anti-spike protein serological testing will likely become increasingly important. Here, we investigated the performance characteristics of the recently FDA-authorized semiquantitative anti-spike protein AdviseDx...

Descripción completa

Detalles Bibliográficos
Autores principales: Bradley, Benjamin T., Bryan, Andrew, Fink, Susan L., Goecker, Erin A., Roychoudhury, Pavitra, Huang, Meei-Li, Zhu, Haiying, Chaudhary, Anu, Madarampalli, Bhanupriya, Lu, Joyce Y. C., Strand, Kathy, Whimbey, Estella, Bryson-Cahn, Chloe, Schippers, Adrienne, Mani, Nandita S., Pepper, Gregory, Jerome, Keith R., Morishima, Chihiro, Coombs, Robert W., Wener, Mark, Cohen, Seth, Greninger, Alexander L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Immunoassays
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373027/
https://www.ncbi.nlm.nih.gov/pubmed/34165323
http://dx.doi.org/10.1128/JCM.00989-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373027/
https://www.ncbi.nlm.nih.gov/pubmed/34165323
http://dx.doi.org/10.1128/JCM.00989-21

Ejemplares similares